Vancomycin hydrochloride NEW
| Price | $54 |
| Package | 1g |
| Supply Ability: | 10g |
| Update Time: | 2025-05-01 |
Product Details
| Product Name: Vancomycin hydrochloride | CAS No.: 1404-93-9 |
| Purity: 99.19% | Supply Ability: 10g |
| Release date: 2025/05/01 |
Product Introduction
Bioactivity
| Name | Vancomycin hydrochloride |
| Description | Vancomycin hydrochloride (Vancomycin HCl) is the hydrochloride salt of vancomycin, a branched tricyclic glycosylated peptide with bactericidal activity against most organisms and bacteriostatic effect on enterococci. |
| In vitro | Vancomycin, a substantial glycopeptide antibiotic with a molecular weight of 1450 Da[1], stands out due to its unique structure and mode of action, distinguishing it from all currently available antibiotics. Its distinctive mechanism targets and inhibits the second stage of cell wall synthesis in susceptible bacteria. Active against an extensive array of Gram-positive species including Staphylococcus aureus, Staph. epidermidis, Str. agalactiae, Str. bovis, Str. mutans, viridans streptococci, and enterococci[2], vancomycin is a critical asset in treating various bacterial infections. |
| In vivo | Vancomycin is administered via intravenous infusion over a minimum of one hour to reduce the risk of infusion-related adverse effects. In individuals with normal creatinine clearance levels, the distribution phase (α) of vancomycin spans between 30 minutes to 1 hour, while the elimination half-life (β) ranges from 6 to 12 hours. Its distribution volume lies between 0.4–1 L/kg, and its protein-binding capacity varies between 10% and 50%. The efficacy of vancomycin is influenced by factors such as tissue distribution, inoculum size, and protein-binding impacts. Furthermore, vancomycin therapy in infected mice demonstrates significant improvements in clinical outcomes, diarrhea, histopathological scores, and survival rates during the course of treatment. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | H2O : 33.33 mg/mL (22.43 mM), Sonication is recommended. DMSO : 55 mg/mL (37.02 mM), Sonication and heating are recommended. |
| Keywords | Vancomycin Hydrochloride | Vancomycin hydrochloride | Vancomycin | Inhibitor | inhibit | Cellwall | Cell wall | cell wall | Bacterial | Autophagy | Antibiotic |
| Inhibitors Related | Neomycin sulfate | Stavudine | Ampicillin sodium | Kanamycin sulfate | Sodium 4-phenylbutyrate | Sulfamethoxazole sodium | Hydroxychloroquine | Guanidine hydrochloride | Doxycycline | Paeonol | Naringin | Dimethyl sulfoxide |
| Related Compound Libraries | Polyphenolic Natural Product Library | Bioactive Compound Library | Cyclic Peptide Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Natural Product Library | Microbial Natural Product Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Immunology/Inflammation Compound Library | Anti-infective Natural Product Library | Anti-Cancer Drug Library |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-06-05 | ||
|
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-06-04 | ||
| $10.50 |
VIP5Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2026-05-28 | |
|
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2026-05-20 | ||
| $54.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | |
| $54.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-04-20 | |
| $5.00 |
Wuhan JiyunZen Tech Co., Ltd.
|
2026-04-10 | ||
| $1.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2026-03-20 | ||
|
VIP3Y
|
Hangzhou ICH Biofarm Co., Ltd
|
2026-01-04 | ||
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2025-12-01 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY